ArticleInternational journal of clinical oncology2026
A phase 1 dose-finding and pharmacokinetic study of acasunlimab alone or in combination with pembrolizumab in Japanese patients with advanced or metastatic solid tumors.
Noboru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.